000 | 01869 a2200481 4500 | ||
---|---|---|---|
005 | 20250515221610.0 | ||
264 | 0 | _c20100514 | |
008 | 201005s 0 0 eng d | ||
022 | _a0303-6995 | ||
024 | 7 |
_a10.1007/978-3-211-92660-4_15 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSilva, Camila | |
245 | 0 | 0 |
_aInvolvement of astroglial fibroblast growth factor-2 and microglia in the nigral 6-OHDA parkinsonism and a possible role of glucocorticoid hormone on the glial mediated local trophism and wound repair. _h[electronic resource] |
260 |
_bJournal of neural transmission. Supplementum _c2009 |
||
300 |
_a185-202 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdrenalectomy _xmethods |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCD11b Antigen _xmetabolism |
650 | 0 | 4 |
_aCorpus Striatum _xcytology |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aFibroblast Growth Factor 2 _xgenetics |
650 | 0 | 4 | _aFunctional Laterality |
650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
650 | 0 | 4 |
_aGlial Fibrillary Acidic Protein _xmetabolism |
650 | 0 | 4 |
_aGlucocorticoids _xmetabolism |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMicroglia _xdrug effects |
650 | 0 | 4 | _aOxidopamine |
650 | 0 | 4 |
_aParkinsonian Disorders _xchemically induced |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 | _aStatistics, Nonparametric |
650 | 0 | 4 |
_aSubstantia Nigra _xpathology |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aTyrosine 3-Monooxygenase _xmetabolism |
650 | 0 | 4 |
_aVentral Tegmental Area _xdrug effects |
650 | 0 | 4 |
_aWound Healing _xdrug effects |
700 | 1 | _aFuxe, Kjell | |
700 | 1 | _aChadi, Gerson | |
773 | 0 |
_tJournal of neural transmission. Supplementum _gno. 73 _gp. 185-202 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/978-3-211-92660-4_15 _zAvailable from publisher's website |
999 |
_c19769410 _d19769410 |